Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019.
作者信息
Lazzeri Chiara, Bonizzoli Manuela, Franci Andrea, Socci Filippo, Peris Adriano
机构信息
Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
出版信息
Intern Emerg Med. 2020 Sep;15(6):1081-1083. doi: 10.1007/s11739-020-02460-7. Epub 2020 Jul 29.
Abstract
摘要
相似文献
1
Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019.2019冠状病毒病非危重症住院患者的肺栓塞及合并近端深静脉血栓形成的筛查
Intern Emerg Med. 2020 Sep;15(6):1081-1083. doi: 10.1007/s11739-020-02460-7. Epub 2020 Jul 29.
2
Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019.2019年冠状病毒病非危重症住院患者的肺栓塞及合并近端深静脉血栓形成的筛查
Intern Emerg Med. 2020 Aug;15(5):865-870. doi: 10.1007/s11739-020-02416-x. Epub 2020 Jun 26.
3
COVID-19 Associated Coagulopathy and Thrombotic Complications.新型冠状病毒肺炎相关凝血病及血栓形成并发症
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620948137. doi: 10.1177/1076029620948137.
4
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.COVID-19 全人群前瞻性队列中静脉血栓栓塞症的发生率。
J Thromb Thrombolysis. 2020 Oct;50(3):558-566. doi: 10.1007/s11239-020-02202-8.
5
Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.武汉48例重症新型冠状病毒肺炎患者下肢深静脉血栓形成的极高发生率
Circulation. 2020 Jul 14;142(2):181-183. doi: 10.1161/CIRCULATIONAHA.120.047407. Epub 2020 May 15.
6
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome.中国武汉 COVID-19 住院患者的深静脉血栓形成：患病率、危险因素和结局。
Circulation. 2020 Jul 14;142(2):114-128. doi: 10.1161/CIRCULATIONAHA.120.046702. Epub 2020 May 18.
7
Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.COVID-19 相关急性肺栓塞：7 例患者初步报告。
Int J Cardiol. 2020 Aug 15;313:129-131. doi: 10.1016/j.ijcard.2020.04.028. Epub 2020 May 26.
8
The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.意大利伦巴第大区在新冠疫情最初几周的“静脉视角”
Phlebology. 2020 Jun;35(5):295-296. doi: 10.1177/0268355520925727. Epub 2020 May 7.
9
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients.COVID-19 住院患者深静脉血栓形成的发生率及危险因素。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620953217. doi: 10.1177/1076029620953217.
10
Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).新冠肺炎危重症患者的静脉血栓栓塞症。
JAMA Netw Open. 2020 May 1;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.
引用本文的文献
1
A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH.对预测COVID-19住院患者静脉血栓栓塞的生物标志物的系统评价：来自国际血栓与止血学会（ISTH）预测与诊断变量科学与标准化委员会的交流
Res Pract Thromb Haemost. 2022 Aug 26;6(6):e12786. doi: 10.1002/rth2.12786. eCollection 2022 Aug.
2
Combined lung and cardiac ultrasound in COVID-related acute respiratory distress syndrome.肺心超声在新冠相关急性呼吸窘迫综合征中的应用。
Intern Emerg Med. 2021 Oct;16(7):1779-1785. doi: 10.1007/s11739-021-02646-7. Epub 2021 Mar 11.
本文引用的文献
1
COVID-19, coagulopathy and venous thromboembolism: more questions than answers.COVID-19、凝血功能障碍与静脉血栓栓塞：问题多于答案。
Intern Emerg Med. 2020 Nov;15(8):1375-1387. doi: 10.1007/s11739-020-02432-x. Epub 2020 Jul 11.
2
Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019.2019年冠状病毒病非危重症住院患者的肺栓塞及合并近端深静脉血栓形成的筛查
Intern Emerg Med. 2020 Aug;15(5):865-870. doi: 10.1007/s11739-020-02416-x. Epub 2020 Jun 26.
3
COVID-19 and the endothelium.COVID-19 与血管内皮。
Clin Hemorheol Microcirc. 2020;75(1):7-11. doi: 10.3233/CH-209007.
4
The unique characteristics of COVID-19 coagulopathy.COVID-19 凝血功能障碍的独特特征。
Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0.
5
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.管理新冠疫情封锁和重新开放阶段的抗凝治疗。
Intern Emerg Med. 2020 Aug;15(5):783-786. doi: 10.1007/s11739-020-02391-3. Epub 2020 Jun 8.
6
The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted.新型冠状病毒肺炎（COVID-19）重症患者血栓形成并发症的负担：探索未知领域。
Intern Emerg Med. 2020 Aug;15(5):893-895. doi: 10.1007/s11739-020-02393-1. Epub 2020 Jun 5.
7
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.新型冠状病毒肺炎住院患者中严重急性呼吸综合征冠状病毒2诱导的凝血病与预后：来自意大利的一则简讯
Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26.
8
Does this patient have COVID-19? A practical guide for the internist.这个患者患有 COVID-19 吗？内科医生实用指南。
Intern Emerg Med. 2020 Aug;15(5):791-800. doi: 10.1007/s11739-020-02377-1. Epub 2020 May 23.
9
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.新型冠状病毒肺炎住院患者从口服抗凝剂转换为胃肠外给予肝素：评论
Intern Emerg Med. 2021 Mar;16(2):519-520. doi: 10.1007/s11739-020-02373-5. Epub 2020 May 21.
10
Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.了解新冠肺炎危重症患者止血障碍的病理生理学。
Intensive Care Med. 2020 Aug;46(8):1603-1606. doi: 10.1007/s00134-020-06088-1. Epub 2020 May 15.
Zotero 插件